𝔖 Bobbio Scriptorium
✦   LIBER   ✦

RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma

✍ Scribed by Lillian Shuk-Nga Chow; Kwok-Wai Lo; Joseph Kwong; Ka-Fai To; Kam-Sze Tsang; Ching-Wan Lam; Reinhard Dammann; Dolly P. Huang

Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
660 KB
Volume
109
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Deletion on the short arm of chromosome 3 is one of the most important genetic abnormalities in the tumorigenesis of nasopharyngeal carcinoma (NPC). Both physical mapping and functional studies have targeted an NPC‐related tumor suppressor gene(s) to chromosome 3p21.3. We have reported recently that RASSF1A gene, located on a 120‐kb minimal deletion region on 3p21.3, was frequently inactivated by promoter hypermethylation in NPC. We further confirmed that RASSF1A is the critical target tumor suppressor from 3p21.3, with the evidence that loss of expression and aberrant methylation of the other 8 candidate genes/transcripts (HYAL2, FUS1, RASSF1C, BLU, NPRL2, 101F6, PL6 and CACNA2D2) in this 120‐kb region were rare in NPC samples. The contribution of RASSF1A in NPC tumorigenesis was investigated by restoring its expression in a RASSF1A deficient cell line, C666‐1. Transient transfection of wild‐type RASSF1A resulted in marked growth inhibition in NPC cells. Isolated stable clones expressing wild‐type RASSF1A demonstrated retarded cell proliferation in vitro. Soft‐agar assay also showed decreased number and sizes of colony formed in these clones. In vivo nude mice assay demonstrated the dramatic reduction of tumorigenic potential in the RASSF1A‐transfected clones. Our results provide strong evidence to support RASSF1A as a target tumor suppressor gene on 3p21.3 in NPC. © 2004 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Alterations of BLU, a candidate tumor su
Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma
✍ Xiao-Qiong Liu; Han-Kui Chen; Xiao-Shi Zhang; Zhi-Gang Pan; Ang Li; Qi-Sheng Fen 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 518 KB

## Abstract Nonrandom allelic loss on chromosome 3p is a common event in nasopharyngeal carcinoma (NPC) with the implication that certain tumor suppressor gene(s) in this region are involved in the pathogenesis of these tumors. The __BLU__ gene, located at 3p21.3, has recently been identified as a

Functional studies of the chromosome 3p2
Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma
✍ Wing Lung Yau; Hong Lok Lung; Eugene R. Zabarovsky; Michael I. Lerman; Jonathan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 216 KB

## Abstract Chromosome 3p plays an important role in tumorigenesis in many cancers, including nasopharyngeal carcinoma (NPC). We have previously shown chromosome 3p can suppress tumor growth __in vivo__ by using the monochromosome transfer approach, which indicated the chromosome 3p21.3 region was

A survey of methylated candidate tumor s
A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma
✍ Myriam Loyo; Mariana Brait; Myoung S. Kim; Kimberly L. Ostrow; Chunfa C. Jie; Al 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 436 KB 👁 1 views

## Abstract Nasopharyngeal carcinoma (NPC) is a rare malignancy with unique genetic, viral and environmental characteristic that distinguishes it from other head and neck carcinomas. The clinical management of NPC remains challenging largely due to the lack of early detection strategies for this tu

A 3p21.3 region is preferentially elimin
A 3p21.3 region is preferentially eliminated from human chromosome 3/mouse microcell hybrids during tumor growth in SCID mice
✍ Irina Kholodnyuk; Marija Kost-Alimova; Vladimir Kashuba; Rinat Gizatulin; Anna S 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

We have previously shown that four markers spanning the 3p24-p21.3 region, THRB, AP20R, D3S1029, and D3S32, were regularly eliminated from three human chromosome 3 (chr3)/mouse microcell hybrids (MCHs) during tumor growth in SCID mice. In an attempt to narrow down the eliminated region, we have stud

Human cell lines engineered for tetracyc
Human cell lines engineered for tetracycline-regulated expression of tumor suppressor candidate genes from a frequently affected chromosomal region, 3p21
✍ Alexei I. Protopopov; Jinfeng Li; Gösta Winberg; Rinat Z. Gizatullin; Vladimir I 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

## Abstract ## Background We modified a tetracycline‐regulated system that can control the activity of individual genes quantitatively and reversibly in transgenic mammals. Despite these advances, there remained one problem in the intensive use of the tet‐system: the limited range of acceptor cell

Localization of a tumor suppressor gene
Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3
✍ Hiroyoshi Suzuki; Miburu Emi; Akira Komiya; Yoshiyuki Fujiwara; Ryuichi Yatani; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 529 KB

Human prostate cancers frequently show loss of heterozygosity at loci on the short arm of chromosome 8. In order t o take a step toward isolation of the putative tumor suppressor gene(s) on 8p via positional cloning, we performed high-resolution deletion mapping in 46 prostate cancers (stage B, 20 c